These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6970768)

  • 1. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1981 Apr; 126(4):1318-22. PubMed ID: 6970768
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity.
    Mills GB; Carlson G; Paetkau V
    J Immunol; 1980 Nov; 125(5):1904-9. PubMed ID: 6968766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.
    Cheever MA; Greenberg PD; Fefer A; Gillis S
    J Exp Med; 1982 Apr; 155(4):968-80. PubMed ID: 6977616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: effect of culture duration on therapeutic efficacy.
    Cheever MA; Greenberg PD; Fefer A
    J Natl Cancer Inst; 1981 Jul; 67(1):169-73. PubMed ID: 6942187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.
    Wang BS; Heacock EH; Zheng CX; Tilney NL; Mannick JA
    Transplantation; 1982 Apr; 33(4):454-6. PubMed ID: 6978560
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
    Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M
    Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis.
    Gillis S; Mertelsmann R; Moore MA
    Transplant Proc; 1981 Dec; 13(4):1884-90. PubMed ID: 6977222
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
    Rosenstein M; Rosenberg SA
    J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of spontaneous murine breast tumors by human interleukin 2-stimulated syngeneic T-lymphocytes.
    Merluzzi VJ; Savage DM; Souza L; Boone T; Mertelsmann R; Welte K; Last-Barney K
    Cancer Res; 1985 Jan; 45(1):203-6. PubMed ID: 3871172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.
    Eberlein TJ; Rosenstein M; Rosenberg SA
    J Exp Med; 1982 Aug; 156(2):385-97. PubMed ID: 6980254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: II. Comparison of cells cultured with and without tumor to noncultured immune cells.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1978 Dec; 121(6):2220-7. PubMed ID: 152790
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity.
    Katsanis E; Xu Z; Anderson PM; Dancisak BB; Bausero MA; Weisdorf DJ; Blazar BR; Ochoa AC
    Bone Marrow Transplant; 1994 Oct; 14(4):563-72. PubMed ID: 7858530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy.
    Zhang S; Wang Q; Li WF; Wang HY; Zhang HJ; Zhu JJ
    Eksp Onkol; 2004 Mar; 26(1):55-62. PubMed ID: 15112581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor neutralization, immunotherapy, and chemoimmmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro.
    Cheever MA; Kempf RA; Fefer A
    J Immunol; 1977 Aug; 119(2):714-8. PubMed ID: 886192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.